PAK4 is the most widely studied of the group II PAKs and has been shown to contribute significantly to cancer cell invasion in gastric cancer40, glioma41, choriocarcinoma42 and prostate35, 38 among others, both in vitro and in vivo. Here, PAK4 is linked to cancer.